Kawasaki syndrome is one of the commonest vasculitides in pediatric age group with devastating consequences if not treated early. Intravenous Gammaglobulin leads to rapid amelioration of clinical symptoms and significantly decreases the risk of development of coronary artery aneurysms. Occasionally, Kawasaki disease may be resistant to I/V IgG. We present our experience with one such patient who ultimately respondend to infliximab therapy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s12098-008-0084-8 | DOI Listing |
Publication Analysis
Top Keywords
kawasaki syndrome
8
infliximab treatment
4
treatment refractory
4
refractory kawasaki
4
syndrome kawasaki
4
syndrome commonest
4
commonest vasculitides
4
vasculitides pediatric
4
pediatric age
4
age group
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!